Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ... 07/17/2012 - 12:35 pm | View Link
Vivus Wins FDA Approval MINYANVILLE ORIGINAL Vivus (VVUS) shareholders got a piece of good news late last week when the Food and Drug Administration approved the ... a decision on market clearance in April but the FDA delayed doing so until July 17. "The majority of the value ... 04/30/2012 - 12:40 pm | View Link
Vivus' Erectile Dysfunction Drug Stendra Wins FDA Approval Law360, New York (April 27, 2012, 8:00 PM ET) -- The U.S. Food and Drug Administration on Friday approved Vivus Inc.'s erectile dysfunction pill Stendra, the first erectile dysfunction treatment to be allowed for use in the U.S. in a decade and the first ... 04/27/2012 - 2:00 pm | View Link
Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges Trading in Vivus stock was halted yesterday before the FDA panel vote. NeuroSearch, which is developing tesofensine for obesity, climbed 5.6 percent to 17 kroner and Novo Nordisk, which is studying its Victoza diabetes drug as a weight-loss treatment ... 02/23/2012 - 8:23 am | View Link
Vivus Weight-Loss Pill Wins Backing of FDA Panel Advisers to the Food and Drug Administration voted 20-2 Wednesday that Qnexa’s benefits outweigh its risks at a meeting at agency headquarters in Silver Spring, Maryland. The FDA isn’t required to follow the panel’s recommendation. The agency is ... 02/22/2012 - 9:50 am | View Link
VVUS News Updated news for VIVUS Inc. - including VVUS company news, press releases and other industry & stock market news. 02/1/2015 - 5:22 am | View Website
VVUS Stock Quote Updated stock quote for VVUS - including VVUS stock price today, earnings and estimates, stock charts, news, futures and other investing data. 02/1/2015 - 1:26 am | View Website
Vivus View detailed financial information, real-time news, videos, quotes and analysis on Vivus (NASDAQ:VVUS). Explore commentary on Vivus and hear what the experts at ... 01/31/2015 - 11:39 pm | View Website
Breaking News – RTTNews Get the latest Breaking News, headlines, business news and more on RTTNews.com 01/31/2015 - 5:41 pm | View Website
The Newest FDA-Approved Obesity Drug Is Also the Oldest (NVO) Novo Nordisk gains FDA approval for Saxenda, which is already approved as an obesity treatment called Victoza. - Brian Orelli - Health Care 12/27/2014 - 7:59 am | View Website
Budweiser is making its pitch again this year for top commercial in Sunday’s Super Bowl with another emotional mini-drama, “Lost Dog,” a 60-second spot featuring a puppy and his best friends, the famous Bud Clydesdale horses in a story of true friendship. It’s a sequel Bud’s Super Bowl spot from last year.
And if this year’s version looks a little familiar to you, don’t be surprised.